D-TUBOCURARINE CHLORIDE for CHEST SURGERY by T

Total Page:16

File Type:pdf, Size:1020Kb

D-TUBOCURARINE CHLORIDE for CHEST SURGERY by T Postgrad Med J: first published as 10.1136/pgmj.24.276.514 on 1 October 1948. Downloaded from 514 POST GRADUATE MEDICAL JOURNAL October I948 all round sense to other methods but even in its go wrong and create dangers that are just as great, most refined standards it is doubtful whether, if not greater because they are more insidious alone, it serves fully the requirements of the long than those associated with the older, and simpler and severe operations now carried out in the methods. abdomen. Success with inhalational anaesthesia The observation so often made in the past that demands a much higher degree of technical dex- the choice of the anaesthetist is more important terity and more fundamental physiological and than the choice of anaesthetic is indeed truer pharmacological knowledge on the part of the today than ever for the scope for unintentional administrator than ever before. In the hands of foolishness and possible disaster has widened the. inexperienced there are many things that may considerably. A SYSTEM OF ANAESTHESIA USING D-TUBOCURARINE CHLORIDE FOR CHEST SURGERY By T. CECIL GRAY, M.D., D.A., F.F.A., R.C.S. et- Reader in Anaesthesia, University of Liverpool ; Atiaesthetist, Liverpool Chest Surgical Centre The exciting and exploratory spirit which has mechanical disorders in the respiration are likely become apparent of recent years in surgery would to occur. On the affected side the lung will collapsecopyright. have been frustrated were it not that anaesthesia on inspiration and expand on expiration. This advanced contemporaneously. In no field has this phenomenon has been described as 'paradoxical spirit in surgery and this progress in anaesthesia respiration' and it results in a certain amount of been more in evidence than in the radical treat- vitiated air passing from the collapsed to the ment of disease of the thoracic viscera. The normally expanded lung on each inspiration, and, pioneer work of Sauerbruch (I904) in Germany if there is a sufficiently big respiratory excursion, and the modem developments in America and it may lead to the spread of infected secretion into Great Britain have produced an era in which the bronchial tree and so from the diseased to the surgical procedures of a gravity and extent hitherto sound lung. Paradoxical movement of this kind considered impossible have become everyday will cause the mediastinum, if it is mobile, to http://pmj.bmj.com/ events. The total or partial removal of a lung is swing away from the open side on inspiration and now a rather less hazardous proposition than a back on expiration. This ' flap' may interfere major abdominal operation. Intra-cardiac surgery with the normal inspiratory filling of the opposite and the operative treatment of congenitally lung. and by reducing the venous return to the abnormal vascular channels are possible and new heart result in sudden circulatory collapse. hope has been given to many patients hitherto For these reasons it is advisable during a thora- doomed to starvation by removal and reconsti- coplasty under general anaesthesia and essential in tution of the diseased oesophagus. Moreover the the presence of an open thorax, to control the res- on October 1, 2021 by guest. Protected surgery of tiiberculous disease of the lungs has piration and avoid such irregular movements. progressed far since the first thoracoplasty was Sauerbruch (1904) devised two methods of performed in this country by Mr. H. Morriston counteracting these undesirable effects both of Davies in 1912. It is the purpose of this paper to which depend upon the production of a pressure show how one of the most recent discoveries in gradient between, on the one hand, the atmosphere anaesthesia is playing its part in these advances breathed by the patient and, on the other, the and materially contributing to successful surgery exposed lungs. In his' Unterdruck Kammer' the within the thorax. It is necessary first, however, head of the patient was occluded by an airtight to consider how the upset to a patient consequent rubber diaphragm from a room in which the upon the creation of an open pneumothorax can remainder of his body together with the surgeon be offset by the anaesthetist. and his assistants were subjected to a pressure Controlled resiration. In the presence of an lower than atmospheric. The patient continued to open pneumothorax or when the pleura has been breathe air at atmospheric pressure. Thus when freed from the chest wall in thoracoplasty, certain the chest was opened there was no increase of Postgrad Med J: first published as 10.1136/pgmj.24.276.514 on 1 October 1948. Downloaded from October I948 GRAY: d-Tubocurarine Chloride for Chest Surgery 5I5 pressure on the lungs and the normal respiratory It is, however, not always necessary to produce pressure difference was maintained. Conversely complete apnoea and paradoxical movement can the same effect was achieved by Sauerbruch's be prevented in quiet respiration by exerting alternative method in which the patient's head was slight positive pressure on the rebreathing bag enclosed in an apparatus, the ' Ueberdriick during inspiration. It seems likely that this degree Apparat,' in which the pressure was slightly above of positive pressure will not balance completely the atmospheric. These original methods, however, intra-thoracic negative pressure produced by were not altogether satisfactory and involved the inspiration, particularly on that side of the chest use of complex and bulky apparatus. Meltzer which remains closed and, therefore, the physio- (I909) and later Beecher (I940) achieved the same logical upset will be less than when there are no result by the continuous intra-tracheal insufflation active respiratory movements. This modified con- of air and anaesthetic gases under a pressure trol of the respiration has been preferred except, sufficient to prevent collapse of the lung when the as will be amplified later, when complete apnoea is chest was opened. But this procedure facilitates desirable to assist the operative technique. the spread of infected material to healthy areas of Inaccuracy in terminology is not uncommon the lungs and, according to Crafoord (1938), may and this latter maneouvre has been called by some result in a steadily increasing alveolar carbon ' assisted respiration.' However, in ordinary dioxide tension. assisted respiration there is no attempt by the The advent of closed circuit anaesthesia lead to anaesthetist to control the respiratory movements; the development of a method whereby the anaes- they are simply augmented in order to overcome thetist achieved perfect control of the respiration. the depressant effects of, for example, Cyclopro- The normal respiratory movements of the patient pane or d-Tubocurarine Chloride. are completely abolished and the lungs are arti- The use of d-Tubocurarine Chloride to provide ficially inflated either by mechanical means as in respiratory control. In the past the impaired and Crafoord's spiro-pulsator, or by manual compres- quiet respiration necessary for control has been sion of the rebreathing bag of the anaesthetic achieved by depression of the respiratory centre apparatus. In this way the lungs are inflated and with heavy premedication and- large doses of copyright. deflated rhytihmically and paradoxical respiration anaesthetic agents. Unfortunately, this resulted which depends on active respiratory movement also in depression of the other medullary centres can no longer occur. An added advantage of this which are concerned with the maintenance of the method of controlled respiration is that the move- circulation. Such ' depression anaesthesia' pre- ments of the lungs can be adapted to the require- disposes to shock and not infrequently resulted in ments of the surgeon. Even this maneouvre, how- toxic sequelae and prolonged periods of post- ever, is not without disadvantages for it may pro- operative prostration. The same diminution of duce certain undesirable physiological effects. respiratory movement can be achieved by the use During apnoea the absence of a negative pressure of very light narcosis and judicious doses of d- http://pmj.bmj.com/ within the thorax removes the respiratory venous tubocurarine chloride. pump mechanism and may lead to a deficient d-Tubocurarine chloride is a pure alkaloid filling of the heart during diastole. Perhaps more extracted from a tropical vine, the chondodendron important is the fact that the normal relationship tomentosum, which is found in the Amazonian between the respiration and the intra-pulmonary jungles. For centuries Curare, the name given to blood circulation is disturbed. In normal inspira- extracts of this vine, was known only as a potent tion the alveolar blood capillaries are dilated by arrow poison and not until the time of Claude the negative intra-thoracic pressure and an effective Bemard was its action scientifically investigated. on October 1, 2021 by guest. Protected and efficient interchange of gases between the Isolation of the pure alkaloid by King in I935 blood and alveolar air is thus facilitated. When made possible accurate pharmacological research there is positive pressure on inspiration, as in into the properties of the drug and ultimately complete control of the respiration with apnoea, made safe its clinical application. d-Tubocurarine these capillaries are flattened and many may be chloride produces paralysis of the voluntary emptied. These effects have been investigated on striated muscles. This paralysis is peripheral in animals by Humphries and his colleagues (1938) origin and is due to an interference at the neuro- and they have shown that under similar conditions muscular junction with the conduction of the significant changes may result in both the cardiac nerve impulse from the nerve to its muscle. The output and pulmonary artery pressure. It is pos- muscles of respiration being striated are affected. sible that circulatory changes brought about in It is important to appreciate that paralysis is the this way may have an important bearing on the only significant effect of an injection of d-tubo- outcome of a critical case when there is only a curarine chloride when it is administered in small circulatory reserve.
Recommended publications
  • Use of Chemical Chelators As Reversal Agents for Drug
    (19) TZZ_ _ZZZ_T (11) EP 1 210 090 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 31/724 (2006.01) A61K 31/194 (2006.01) 18.06.2014 Bulletin 2014/25 A61P 39/04 (2006.01) (21) Application number: 00964006.1 (86) International application number: PCT/EP2000/007694 (22) Date of filing: 07.08.2000 (87) International publication number: WO 2001/012202 (22.02.2001 Gazette 2001/08) (54) USE OF CHEMICAL CHELATORS AS REVERSAL AGENTS FOR DRUG- INDUCED NEUROMUSCULAR BLOCK VERWENDUNG VON CHEMISCHEN CHELATOREN ZUR UMKEHRUNG VON PHARMAKOLOGISCH-INDUZIERTER NEUROMUSKULÄRER BLOCKIERUNG UTILISATION D’AGENTS CHIMIQUES CHELATANTS COMME AGENTS DE NEUTRALISATION DU BLOCAGE NEUROMUSCULAIRE PROVOQUE PAR DES MEDICAMENTS (84) Designated Contracting States: (56) References cited: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU AU-A- 3 662 895 MC NL PT SE • B DESIRE: "Inactivaton of sarin and soman by (30) Priority: 13.08.1999 EP 99306411 cyclodextrins in vitro" EXPERIENTIA, vol. 43, no. 4, 1987, pages 395-397, XP000907287 (43) Date of publication of application: • B. DESIRE: "Interaction of soman with beta- 05.06.2002 Bulletin 2002/23 cyclodextrin" FUNDAMENTAL AND APPLIED TOXICOLOGY, vol. 7, no. 4, 1986, pages 647-657, (73) Proprietor: Merck Sharp & Dohme B.V. XP000911170 2031 BN Haarlem (NL) • C. MAY: "Development of a toxin-binding agent as a treatment for tunicamycinuracil toxicity: (72) Inventors: protection against tunicamycin poisoning of • BOM, Antonius, Helena, Adolf sheep" AUSTRALIAN VETERINARY JOURNAL, Ratho, Midlothian EH28 8NY (GB) vol. 76, no.
    [Show full text]
  • Expression of Multiple Populations of Nicotinic Acetylcholine
    EXPRESSION OF MULTIPLE POPULATIONS OF NICOTINIC ACETYLCHOLINE RECEPTORS IN BOVINE ADRENAL CHROMAFFIN CELLS DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in the Graduate School of The Ohio State University By Bryan W. Wenger, B.A. The Ohio State University 2003 Dissertation Committee: Approved by: Professor Dennis B. McKay, Advisor Professor R. Thomas Boyd ________________________ Advisor Professor Popat N. Patil College of Pharmacy Professor Lane Wallace, Ph.D. ABSTRACT The importance of the role of nAChRs in physiological and pathological states is becoming increasingly clear. It is apparent that there are multitudes of nAChR subtypes with different expression patterns, pharmacologies and functions that may be important in various disease states. Therefore, a greater understanding of nAChR subtypes is essential for potential pharmacological intervention in nAChR systems. Bovine adrenal chromaffin cells are a primary culture of a neuronal type cell that express ganglionic types of nAChRs whose activation can be related to a functional response. While much is known about the outcome of functional activation of adrenal nAChRs, little work has been done in characterizing populations of nAChRs in adrenal chromaffin cells. These studies characterize the pharmacology and regulation of populations of nAChRs found in bovine adrenal chromaffin cells. The primary findings of this research include 1) the characterization of an irreversible antagonist of adrenal nAChRs, 2) the discovery of
    [Show full text]
  • (12) United States Patent (10) Patent N0.: US 7,265,099 B1 Born Et A1
    US007265099B1 (12) United States Patent (10) Patent N0.: US 7,265,099 B1 Born et a1. (45) Date of Patent: *Sep. 4, 2007 (54) USE OF CHEMICAL CHELATORS AS Tarver, G. et al “2-O-Substituted cyclodextrins as reversal REVERSAL AGENTS FOR DRUG-INDUCED agents . ” Bioorg. Med. Chem. (2002) vol. 10, pp 1819-1827.* NEUROMUSCULAR BLOCK Zhang, M. “Drug-speci?c cyclodextrins . ” Drugs of the Future (2003) vol. 28, no 4, pp 347-354.* (75) Inventors: Antonius Helena Adolf Bom, Lee, C. “Structure, conformation, and action of neuromuscular Midlothian (GB); Alan William Muir, blocking drugs” Brit. J. Anesth. (2001) vol. 87, no 5, pp 755-769.* Lanark (GB); David Rees, Gothenburg B Desire: “Inactivation of sarin and soman by cyclodextrins in (SE) vitro” EXPERIENTIA, vol. 43, No. 4, 1987, pp. 395-397. B. Desire: “Interaction of soman with beta-cyclodextrin” Funda (73) Assignee: Organon N.V., Oss (NL) mental and Applied Toxicology, vol. 7, No. 4, 1986, pp. 647-657. ( * ) Notice: Subject to any disclaimer, the term of this C. May: “Development of a toxin-bindng agent as a treatment for patent is extended or adjusted under 35 tunicamycinuracil toxicity: protection against tunicamycin poison U.S.C. 154(b) by 0 days. ing of sheep” Australian Veterinary Journal, vol. 76, No. 11, 1998 pp. 752-756. This patent is subject to a terminal dis K. Uekama: “Effects of cyclodextrins on chlorpromaZine-induced claimer. haemolysis and nervous systems responses” J. Pharm. Pharmacol., vol. 33, No. 11, 1981, pp. 707-710. (21) Appl. No.: 10/049,393 T. Irie: “Protective mechanism of beta-cyclodextrin for the hemolysis induced With phenothiazine neuroleptics in vitro” J.
    [Show full text]
  • Pharmacology of Ophthalmologically Important Drugs James L
    Henry Ford Hospital Medical Journal Volume 13 | Number 2 Article 8 6-1965 Pharmacology Of Ophthalmologically Important Drugs James L. Tucker Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal Part of the Chemicals and Drugs Commons, Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons Recommended Citation Tucker, James L. (1965) "Pharmacology Of Ophthalmologically Important Drugs," Henry Ford Hospital Medical Bulletin : Vol. 13 : No. 2 , 191-222. Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol13/iss2/8 This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons. For more information, please contact [email protected]. Henry Ford Hosp. Med. Bull. Vol. 13, June, 1965 PHARMACOLOGY OF OPHTHALMOLOGICALLY IMPORTANT DRUGS JAMES L. TUCKER, JR., M.D. DRUG THERAPY IN ophthalmology, like many specialties in medicine, encompasses the entire spectrum of pharmacology. This is true for any specialty that routinely involves the care of young and old patients, surgical and non-surgical problems, local eye disease (topical or subconjunctival drug administration), and systemic disease which must be treated in order to "cure" the "local" manifestations which frequently present in the eyes (uveitis, optic neurhis, etc.). Few authors (see bibliography) have attempted an introduction to drug therapy oriented specifically for the ophthalmologist. The new resident in ophthalmology often has a vague concept of the importance of this subject, and with that in mind this paper was prepared.
    [Show full text]
  • Pharmacological Review of Chemicals Used for the Capture of Animals
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Proceedings of the 7th Vertebrate Pest Vertebrate Pest Conference Proceedings Conference (1976) collection March 1976 PHARMACOLOGICAL REVIEW OF CHEMICALS USED FOR THE CAPTURE OF ANIMALS Peter J. Savarie U.S. Fish and Wildlife Service Follow this and additional works at: https://digitalcommons.unl.edu/vpc7 Part of the Environmental Health and Protection Commons Savarie, Peter J., "PHARMACOLOGICAL REVIEW OF CHEMICALS USED FOR THE CAPTURE OF ANIMALS" (1976). Proceedings of the 7th Vertebrate Pest Conference (1976). 41. https://digitalcommons.unl.edu/vpc7/41 This Article is brought to you for free and open access by the Vertebrate Pest Conference Proceedings collection at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Proceedings of the 7th Vertebrate Pest Conference (1976) by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. PHARMACOLOGICAL REVIEW OF CHEMICALS USED FOR THE CAPTURE OF ANIMALS* PETEIR J. SAVARIE, U.S. Fish and Wildlife Service, Building 16, Federal Center, Denver, Colorado 80225 ABSTRACT: A review of the literature reveals that over 60 chemicals have been used for the capture of wi l d animals, but only 30 of the most widely used chemicals are discussed in the present paper. For practical considerations these chemicals can be c l a ssified as being either (l) neuromuscular blocking agents, or (2) central nervous system (CNS) depressants. Some common neuromuscular blocking agents are d-tubocurarine, gallamine, succiny1choline, and nicotine. M99 and its derivatives, phencyclidine, and xylazine are some of the more commonly used CNS depressants. Neuromuscular blocking agents have a relatively rapid onset and short duration of action but they do not possess sedative, analgesic, or anesthetic properties.
    [Show full text]
  • USP Endotoxin Limits for Common Injectables
    Pharma&Biotech USP Endotoxin Limits for Common Injectables Updated as of August 2011 For reference use only Pharma&Biotech Updated as of August 2011. For reference use only. USP Endotoxin Limits This information is subject to the disclaimer included on page 13. for Common Injectables This table is for informational purposes only. Endotoxin limits should be set on an individual product basis, using the formula found in the Pharmacopeias (Endotoxin Limit = K/M). Description Endotoxin Limit A Acepromazine Maleate Injection 4.5 EU / mg Acetazolamide for Injection 0.5 EU / mg Acetic Acid Irrigation 0.5 EU / ml Acyclovir for Injection 0.174 EU / mg Adenosine Injection (continuous peripheral intravenous infusion) 5.95 EU / mg Adenosine Injection (rapid intravenous) 11.62 EU / mg Alcohol in Dextrose Injection 0.5 EU / ml Alfentanil Injection 10 EU / ml Alprostadil Injection 0.05 EU / µg Alteplase for Injection 1 EU / mg Amifostine for Injection 0.2 EU / mg Amikacin Sulfate Injection 0.33 EU / mg Aminocaproic Acid Injection 0.05 EU / mg Aminohippurate Sodium Injection 0.04 EU / mg Aminopentamide Sulfate Injection 25 EU / mg Aminophylline Injection 1 EU / mg Ammonium Chloride Injection (of Chloride) 1.72 mEq Cl Amobarbital Sodium for Injection 0.4 EU / mg Amoxicillin, Sterile and Suspension 0.25 EU / mg Amphotericin B for Injection (for Intrathecal) 0.9 EU / mg Amphotericin B for Injection (for Parenterals) 5 EU / mg Ampicillin and Sulbactam for Injection 0.17 EU / (1 mg of mix of amp and sulb - 0.67 and 0.33 mg, respectively) Ampicillin for Injection
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • Known Bioactive Library: Microsource 1 - US Drug Collection
    Known Bioactive Library: Microsource 1 - US Drug Collection ICCB-L ICCB-L Vendor Vendor Compound Name Bioactivity Source CAS Plate Well ID antifungal, inhibits Penicillium 2091 A03 Microsource 00200046 GRISEOFULVIN 126-07-8 mitosis in metaphase griseofulvum 3505-38-2, 486-16-8 2091 A04 Microsource 01500161 CARBINOXAMINE MALEATE antihistaminic synthetic [carbinoxamine] 2091 A05 Microsource 00200331 SALSALATE analgesic synthetic 552-94-3 muscle relaxant 2091 A06 Microsource 01500162 CARISOPRODOL synthetic 78-44-4 (skeletal) antineoplastic, 2091 A07 Microsource 00210369 GALLIC ACID insect galls 149-91-7 astringent, antibacterial 66592-87-8, 50370-12- 2091 A08 Microsource 01500163 CEFADROXIL antibacterial semisynthetic 2 [anhydrous], 119922- 89-9 [hemihydrate] Rheum palmatum, 2091 A09 Microsource 00211468 DANTHRON cathartic 117-10-2 Xyris semifuscata 27164-46-1, 25953-19- 2091 A10 Microsource 01500164 CEFAZOLIN SODIUM antibacterial semisynthetic 9 [cefazolin] glucocorticoid, 2091 A11 Microsource 00300024 HYDROCORTISONE adrenal glands 50-23-7 antiinflammatory 64485-93-4, 63527-52- 2091 A12 Microsource 01500165 CEFOTAXIME SODIUM antibacterial semisynthetic 6 [cefotaxime] 2091 A13 Microsource 00300029 DESOXYCORTICOSTERONE ACETATE mineralocorticoid adrenocortex 56-47-3 58-71-9, 153-61-7 2091 A14 Microsource 01500166 CEPHALOTHIN SODIUM antibacterial semisynthetic [cephalothin] 2091 A15 Microsource 00300034 TESTOSTERONE PROPIONATE androgen, antineoplastic semisynthetic 57-85-2 24356-60-3, 21593-23- 2091 A16 Microsource 01500167 CEPHAPIRIN SODIUM
    [Show full text]
  • Pharmacology
    STATE ESTABLISHMENT «DNIPROPETROVSK MEDICAL ACADEMY OF HEALTH MINISTRY OF UKRAINE» V.I. MAMCHUR, V.I. OPRYSHKO, А.А. NEFEDOV, A.E. LIEVYKH, E.V.KHOMIAK PHARMACOLOGY WORKBOOK FOR PRACTICAL CLASSES FOR FOREIGN STUDENTS STOMATOLOGY DEPARTMENT DNEPROPETROVSK - 2016 2 UDC: 378.180.6:61:615(075.5) Pharmacology. Workbook for practical classes for foreign stomatology students / V.Y. Mamchur, V.I. Opryshko, A.A. Nefedov. - Dnepropetrovsk, 2016. – 186 p. Reviewed by: N.I. Voloshchuk - MD, Professor of Pharmacology "Vinnitsa N.I. Pirogov National Medical University.‖ L.V. Savchenkova – Doctor of Medicine, Professor, Head of the Department of Clinical Pharmacology, State Establishment ―Lugansk state medical university‖ E.A. Podpletnyaya – Doctor of Pharmacy, Professor, Head of the Department of General and Clinical Pharmacy, State Establishment ―Dnipropetrovsk medical academy of Health Ministry of Ukraine‖ Approved and recommended for publication by the CMC of State Establishment ―Dnipropetrovsk medical academy of Health Ministry of Ukraine‖ (protocol №3 from 25.12.2012). The educational tutorial contains materials for practical classes and final module control on Pharmacology. The tutorial was prepared to improve self-learning of Pharmacology and optimization of practical classes. It contains questions for self-study for practical classes and final module control, prescription tasks, pharmacological terms that students must know in a particular topic, medical forms of main drugs, multiple choice questions (tests) for self- control, basic and additional references. This tutorial is also a student workbook that provides the entire scope of student’s work during Pharmacology course according to the credit-modular system. The tutorial was drawn up in accordance with the working program on Pharmacology approved by CMC of SE ―Dnipropetrovsk medical academy of Health Ministry of Ukraine‖ on the basis of the standard program on Pharmacology for stomatology students of III - IV levels of accreditation in the specialties Stomatology – 7.110105, Kiev 2011.
    [Show full text]
  • Atracurium and Severe Hepatic Disease: a Case Report
    161 Atracurium and severe hepatic disease: Henry K. Gyasi Ma CH B FFARCSI, Mohamed Naguib Ma a CH M SC a case report Atracurium is a new non-depolarising neuromuscular venous pressure was 0.9 KPa (9 cmH20). Haemo- blocking agent, metabolized through Hofmann elimina- globin was 8.9 g.d1-1 and the test for sickle cell tion. A case is presented in which a 45-year-old patient haemoglobin was negative. with severe liver disease showed a decreased response This was his first general anaesthetic and there to atracurium. The possible causes of resistance to was no family history of anaesthetic problems. atracurium are discussed. We conclude that atracurium Preoperative serum urea, sodium, potassium may be used in patients with severe hepatic disease. and chloride were within normal limits but total bilirubin was 73.5 txmol'L -I (normal 1.71-18.81 Key words l.Lmol.L -~) total protein 85g.L -t (normal 60-80 NEUROMUSCULAR RELAXANTS: atracurium, g.L -1) and albumin 27 g'L -1 (normal 35-48 g.L-I). succinylcholine; ENZYMES" plasma cholinesterase; The preoperative chest x-ray and ECG were normal. LIVER: function. He was started on a course of metronidazole 250 mg, gentamycin 80 mg and Vitamin K 10mg intravenously. No prernedication was given. The patient arrived in the operating room with a Atracurium besylate is a new non-depolarising solution of Ringer's Lactate in five per cent dextrose neuromuscular blocking agent. It is broken down running via a peripheral vein. A baseline blood in the body through Hofmann elimination, a spon- pressure was measured and subsequently, every taneous non-enzymatic process which is pH and five minutes by an electronic oscillotonometer temperature dependent.~'2 The molecule of atra- (Dinamap).
    [Show full text]
  • Administrative Records, Texas Department of Criminal Justice
    Consistent with the terms of the Court’s May 22, 2017 scheduling order, the record has been redacted for all information that plaintiff, Texas Department of Criminal Justice (Texas), has identified as confidential. In addition, Defendants have also redacted information that the drug’s supplier and broker have separately advised the agency they consider confidential and private, as well as information the agency itself generally treats as confidential. This information has been redacted pending final FDA’s review of confidentiality claims, and our filing of the record with these redactions does not necessarily reflect our agreement with all of the claims of confidentiality Defendants have received. Defendants explicitly reserve the right to make an independent determination regarding the proper scope of redactions at a later time. Should we identify any of Texas’s redactions that are over-broad or otherwise improper, we will work with Texas’s counsel to revise the redactions in the record. MISCELLANEOUS FDA 568 DOCUMENT#: VERSION#: DIOP PROCEDURE ~L ORO-DIOP- 2.00 FOOD & DRUG ADMINISTRATION .008 I OFFICE OF REGULATORY AFFAIRS PAGE 1 OF 4 TITLE: EFFECTIVE DATE: PROCESSING OF SODIUM THIOPENTAL ENTRIES 4/16/2012 Sections included in this document 1. Purpose 2. Scope 3. Responsibility 4. Background 5. References 6. Procedure 7. Definitions/Glossary 8. Records 9. Supporting Documents 10. Contact Information 11.Attachments Document History and Change History 1. Purpose Pending litigation, this procedure provides instructions on the handling of shipments of Sodium Thiopental by Districts and the responsibility of DIOP in the processing of Sodium Thiopental entries. Districts should disseminate this information to all pertinent staff handling these entries.
    [Show full text]
  • 1912 Neuromuscular Blockers
    1912 Neuromuscular Blockers have occurred when used in anaesthetic regimens with propofol block and may be associated with prolonged neu- Preparations and opioids such as fentanyl. romuscular blockade and apnoea. BP 2008: Suxamethonium Chloride Injection; See also under Interactions of Atracurium, p.1904. USP 31: Succinylcholine Chloride for Injection; Succinylcholine Chloride 1. Laurence AS, Henderson P. Serum myoglobin after suxametho- After intravenous injection suxamethonium chloride Injection. nium administration to children: effect of pretreatment before iv (details are given in Part 3) and inhalation induction. Br J Anaesth 1986; 58: 126P. acts in about 30 to 60 seconds and has a duration of Proprietary Preparations action of about 2 to 6 minutes. After intramuscular in- Arg.: Actirelax; Fosfitone; Succi†; Austral.: Scoline; Austria: Lysthenon; Histamine H2 antagonists. See under Atracurium, p.1904. Belg.: Myoplegine†; Braz.: Quelicin; Succitrat; Succnil Colin; Canad.: jection it acts in 2 to 3 minutes and has a duration of Quelicin; Fin.: Sukolin; Fr.: Celocurine†; Ger.: Lysthenon; Pantolax; Gr.: Lithium. See under Atracurium, p.1904. Lycitrope; India: Midarine; Indon.: Quelicin; Irl.: Anectine; Israel: Succinyl; action of about 10 to 30 minutes. Ital.: Midarine; Myotenlis†; Malaysia: Ethicoline; Succinyl†; Mex.: Anec- Local anaesthetics. Procaine, cocaine, and chloroprocaine tine; Uxicolin; Neth.: Curalest; Norw.: Curacit; NZ: Ethicholine†; Pol.: are ester-type local anaesthetics which are hydrolysed by plasma Suxamethonium is used in surgical and other proce- Chlorsuccillin; Port.: Mioflex; Rus.: Lysthenon (Листенон); S.Afr.: Scoline; cholinesterase and may competitively enhance the neuromuscu- dures in which a rapid onset and brief duration of mus- Singapore: Ethicholine; Spain: Anectine; Mioflex; Swed.: Celocurin; lar blocking activity of suxamethonium.
    [Show full text]